NEUROCRINE BIOSCIENCES INC (NBIX) Retained Earnings (Accumulated Deficit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Neurocrine Biosciences Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2010 to 2024.
  • Neurocrine Biosciences Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$114 M, a 76.5% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$114 M +$370 M +76.5% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 -$157 M +$250 M +61.4% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 -$305 M +$191 M +38.5% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 -$388 M +$176 M +31.3% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 -$483 M +$64 M +11.7% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 -$407 M +$229 M +36% Dec 31, 2022 10-K 2024-02-09
Q3 2022 -$496 M +$133 M +21.1% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 -$564 M +$86.7 M +13.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$547 M +$146 M +21% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 -$636 M +$89.6 M +12.4% Dec 31, 2021 10-K 2023-02-09
Q3 2021 -$629 M +$445 M +41.4% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 -$651 M +$365 M +35.9% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 -$693 M +$402 M +36.7% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 -$725 M +$407 M +36% Dec 31, 2020 10-K 2022-02-11
Q3 2020 -$1.07 B +$93.4 M +8.01% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 -$1.02 B +$205 M +16.8% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 -$1.1 B +$177 M +13.9% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$1.13 B +$45.1 M +3.83% Dec 31, 2019 10-K 2021-02-05
Q3 2019 -$1.17 B +$29.1 M +2.44% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 -$1.22 B +$26.1 M +2.09% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 -$1.27 B -$31.1 M -2.51% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 -$1.18 B +$21.1 M +1.76% Dec 31, 2018 10-K 2020-02-07
Q3 2018 -$1.2 B +$9.93 M +0.82% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 -$1.25 B -$52 M -4.35% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 -$1.24 B -$106 M -9.35% Mar 31, 2018 10-Q 2018-04-30
Q4 2017 -$1.2 B -$143 M -13.5% Dec 31, 2017 10-K 2019-02-08
Q3 2017 -$1.21 B -$194 M -19.2% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 -$1.19 B -$220 M -22.6% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$1.13 B -$200 M -21.4% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 -$1.06 B -$141 M -15.4% Dec 31, 2016 10-K 2018-02-13
Q3 2016 -$1.01 B -$126 M -14.2% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 -$975 M -$123 M -14.5% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 -$934 M -$107 M -12.9% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 -$915 M -$88.9 M -10.8% Dec 31, 2015 10-K 2017-02-14
Q3 2015 -$886 M -$79.1 M -9.8% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 -$851 M -$60.5 M -7.65% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 -$827 M -$49.9 M -6.42% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 -$826 M -$60.5 M -7.91% Dec 31, 2014 10-K 2016-02-11
Q3 2014 -$807 M -$51.7 M -6.85% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 -$791 M -$47 M -6.32% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 -$778 M -$45.9 M -6.27% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 -$766 M -$46.1 M -6.4% Dec 31, 2013 10-K 2015-02-09
Q3 2013 -$755 M -$26 M -3.56% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 -$744 M -$17.9 M -2.47% Jun 30, 2013 10-Q 2013-07-26
Q1 2013 -$732 M -$6.16 M -0.85% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 -$720 M +$5.03 M +0.69% Dec 31, 2012 10-K 2014-02-11
Q3 2012 -$729 M -$3.13 M -0.43% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 -$726 M +$31.3 M +4.14% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 -$726 M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 -$725 M +$37.6 M +4.93% Dec 31, 2011 10-K 2013-02-08
Q3 2011 -$726 M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 -$757 M Jun 30, 2011 10-Q 2011-07-29
Q4 2010 -$762 M Dec 31, 2010 10-K 2012-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.